Skip to main content
HIKMA Pharmaceuticals PLC logo

HIKMA Pharmaceuticals PLC — Investor Relations & Filings

Ticker · HIK ISIN · GB00B0LCW083 LEI · 549300BNS685UXH4JI75 IL Manufacturing
Open in API
Filings indexed 797 across all filing types
Latest filing 2026-05-01 Declaration of Voting R…
Country GB United Kingdom
Listing IL HIK

About HIKMA Pharmaceuticals PLC

https://www.hikma.com/home/

Hikma Pharmaceuticals is a global pharmaceutical company that develops, manufactures, and markets a broad portfolio of pharmaceutical products. The company's offerings include a wide range of generic, branded, specialty, and in-licensed medicines. It is a significant supplier of generic injectable products to hospitals and also provides oral generics and other specialty medications. With a focus on producing high-quality medicines, Hikma aims to make its products accessible to patients and healthcare providers across its key markets in North America, Europe, and the Middle East & North Africa (MENA) region.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2026-05-01 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is an RNS announcement disclosing a transaction by a Person Discharging Managerial Responsibilities (PDMR) – specifically, a share purchase by the Non-Executive Chair. This matches the definition of Director’s Dealing (insider share transactions by company directors/executives).
2026-04-28 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document is an RNS notice under the UK’s National Storage Mechanism titled “Transaction in Own Shares” by Hikma Pharmaceuticals PLC. It details the number of ordinary shares repurchased under a share buyback programme, including aggregate volumes, prices, and a schedule of individual trades. This matches the definition for “Transaction in Own Shares” (share repurchase/issuance) rather than a broader regulatory or earnings report.
2026-04-27 English
Special Business passed at AGM
AGM Information Classification · 1% confidence The document is the formal resolutions passed at the company’s Annual General Meeting held on 23 April 2026, detailing share authorities, buyback powers, and other AGM agenda items. It is not an earnings release, legal proceeding update, or other report type but clearly AGM materials. Therefore, it falls under AGM Information (AGM-R).
2026-04-23 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an RNS announcement titled “Results of 2026 Annual General Meeting” detailing vote counts and percentages for each resolution at the AGM. It provides the official polling results, including votes for, against, withheld, and shares cast, as well as related dividend declarations and Rule 9 waiver approvals – matching the definition of a Declaration of Voting Results & Voting Rights Announcement.
2026-04-23 English
Trading Statement
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement providing a trading update and reaffirmation of full-year guidance, ahead of the Annual General Meeting. It is not a full Annual Report (10-K), Interim Report (IR), Earnings Release (ER) of results, or any other defined standalone report. It is a general regulatory announcement, so falls into the fallback category Regulatory Filings (RNS).
2026-04-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.